PPLPHARMA — Piramal Pharma (Mumbai) Share News
0.000.00%
Last trade - 00:00- IN₹210.84bn
- IN₹253.37bn
- IN₹88.69bn
Brief: Piramal Pharma To Sell Plot Of Land, Factory For About 90 Mln Rupees
Brief: Piramal Pharma To Enter Into Agreements With Clean Max Aero, Clean Max Enviro Energy Solutions
India's Piramal Pharma up after US FDA ends inspection at facility
India's Piramal Pharma up as USFDA inspection ends at US facility
Brief: Piramal Pharma Says US FDA Inspection At Piramal Pharma's Manufacturing Facility Located At Lexington, USA
India's Piramal Pharma gains after upbeat Q4 results
Brief: Piramal Pharma March-Quarter Consol Net PAT Rises
India's Piramal Pharma up after FDA closes inspection of US facility
Brief: Piramal Pharma Says Closure Of Us FDA Inspection At Piramal Pharma's Manufacturing Facility Located At Riverview, Usa
Consumer Products Division Has Announced Its Foray Into Men's Personal Grooming Category
India's Piramal Pharma gains on anti-dumping probe on import of key product
Jefferies says Piramal Pharma at attractive valuation; shares up
Brief: Piramal Pharma Says Fine Of Euros 182,001 Imposed On Unit By Audiencia Nacional, Spain
India's Piramal Pharma hits over 1-yr high on posting quarterly profit
Brief: Piramal Pharma Posts Dec-Quarter Consol Net PAT
Icici Securities Re: initiates India's Piramal Pharma; shares up
Brief: Piramal Pharma Says VetDC Initiated Civil Suit Making Claims In Relation To Batches Of Product Manufactured During 2018-2019 Against Unit
Focus: Indian drug manufacturers benefit from Big Pharma interest beyond China
India's Piramal Pharma margins may reach high-teens by FY26 - Jefferies